HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrate.

AuthorsToni M Brand, Deric L Wheeler
JournalCancer biology & therapy (Cancer Biol Ther) Vol. 11 Issue 3 Pg. 368-70 (Feb 01 2011) ISSN: 1555-8576 [Electronic] United States
PMID21228636 (Publication Type: Journal Article, Comment)
Chemical References
  • Citrates
  • lithium citrate
  • Phosphatidylinositol 3-Kinases
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CA protein, human
  • ErbB Receptors
Topics
  • Breast Neoplasms (drug therapy, genetics)
  • Citrates (therapeutic use)
  • Class I Phosphatidylinositol 3-Kinases
  • ErbB Receptors (genetics, metabolism)
  • Female
  • Humans
  • Phosphatidylinositol 3-Kinases (genetics, metabolism)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: